Literature DB >> 35862685

The Population Genomics of Increased Virulence and Antibiotic Resistance in Human Commensal Escherichia coli over 30 Years in France.

Erick Denamur1,2,3, François Blanquart4, Julie Marin1,2, Olivier Clermont1,2, Guilhem Royer1,2,5,6, Mélanie Mercier-Darty7, Jean Winoc Decousser6,8, Olivier Tenaillon1,2.   

Abstract

Escherichia coli is a commensal species of the lower intestine but is also a major pathogen causing intestinal and extraintestinal infections that is increasingly prevalent and resistant to antibiotics. Most studies on genomic evolution of E. coli used isolates from infections. Here, instead, we whole-genome sequenced a collection of 403 commensal E. coli isolates from fecal samples of healthy adult volunteers in France (1980 to 2010). These isolates were distributed mainly in phylogroups A and B2 (30% each) and belonged to 152 sequence types (STs), the five most frequent being ST10 (phylogroup A; 16.3%), ST73 and ST95 (phylogroup B2; 6.3 and 5.0%, respectively), ST69 (phylogroup D; 4.2%), and ST59 (phylogroup F; 3.9%), and 224 O:H serotypes. ST and serotype diversity increased over time. The O1, O2, O6, and O25 groups used in bioconjugate O-antigen vaccine against extraintestinal infections were found in 23% of the strains of our collection. The increase in frequency of virulence-associated genes and antibiotic resistance was driven by two evolutionary mechanisms. Evolution of virulence gene frequency was driven by both clonal expansion of STs with more virulence genes ("ST-driven") and increases in gene frequency within STs independent of changes in ST frequencies ("gene-driven"). In contrast, the evolution of resistance was dominated by increases in frequency within STs ("gene-driven"). This study provides a unique picture of the phylogenomic evolution of E. coli in its human commensal habitat over 30 years and will have implications for the development of preventive strategies. IMPORTANCE Escherichia coli is an opportunistic pathogen with the greatest burden of antibiotic resistance, one of the main causes of bacterial infections and an increasing concern in an aging population. Deciphering the evolutionary dynamics of virulence and antibiotic resistance in commensal E. coli is important to understand adaptation and anticipate future changes. The gut of vertebrates is the primary habitat of E. coli and probably where selection for virulence and resistance takes place. Unfortunately, most whole-genome-sequenced strains are isolated from pathogenic conditions. Here, we whole-genome sequenced 403 E. coli commensals isolated from healthy French subjects over a 30-year period. Virulence genes increased in frequency by both clonal expansion of clones carrying them and increases in frequency within clones, whereas resistance genes increased by within-clone increased frequency. Prospective studies of E. coli commensals should be performed worldwide to have a broader picture of evolution and adaptation of this species.

Entities:  

Keywords:  Escherichia coli; antibiotic resistance; commensal; evolution; genomics; virulence

Mesh:

Substances:

Year:  2022        PMID: 35862685      PMCID: PMC9361829          DOI: 10.1128/aem.00664-22

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   5.005


  74 in total

1.  Genealogical Working Distributions for Bayesian Model Testing with Phylogenetic Uncertainty.

Authors:  Guy Baele; Philippe Lemey; Marc A Suchard
Journal:  Syst Biol       Date:  2015-11-01       Impact factor: 15.683

2.  Virulence factor profiles, phylogenetic background, and antimicrobial resistance pattern of lactose fermenting and nonlactose fermenting Escherichia coli from extraintestinal sources.

Authors:  Arindam Chakraborty; Prabha Adhikari; Shalini Shenoy; Vishwas Saralaya
Journal:  Indian J Pathol Microbiol       Date:  2016 Apr-Jun       Impact factor: 0.740

Review 3.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

4.  MAFFT multiple sequence alignment software version 7: improvements in performance and usability.

Authors:  Kazutaka Katoh; Daron M Standley
Journal:  Mol Biol Evol       Date:  2013-01-16       Impact factor: 16.240

5.  Real-time PCR for quantitative analysis of human commensal Escherichia coli populations reveals a high frequency of subdominant phylogroups.

Authors:  Mounira Smati; Olivier Clermont; Frédéric Le Gal; Olivier Schichmanoff; Françoise Jauréguy; Alain Eddi; Erick Denamur; Bertrand Picard
Journal:  Appl Environ Microbiol       Date:  2013-06-14       Impact factor: 4.792

6.  Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.

Authors:  V de Lastours; C Laouénan; G Royer; E Carbonnelle; R Lepeule; M Esposito-Farèse; O Clermont; X Duval; B Fantin; F Mentré; J W Decousser; E Denamur; A Lefort
Journal:  J Antimicrob Chemother       Date:  2020-08-01       Impact factor: 5.790

7.  Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: a study of electronic health records.

Authors:  Karina-Doris Vihta; Nicole Stoesser; Martin J Llewelyn; T Phuong Quan; Tim Davies; Nicola J Fawcett; Laura Dunn; Katie Jeffery; Chris C Butler; Gail Hayward; Monique Andersson; Marcus Morgan; Sarah Oakley; Amy Mason; Susan Hopkins; David H Wyllie; Derrick W Crook; Mark H Wilcox; Alan P Johnson; Tim E A Peto; A Sarah Walker
Journal:  Lancet Infect Dis       Date:  2018-08-17       Impact factor: 25.071

8.  Bayesian phylogenetics with BEAUti and the BEAST 1.7.

Authors:  Alexei J Drummond; Marc A Suchard; Dong Xie; Andrew Rambaut
Journal:  Mol Biol Evol       Date:  2012-02-25       Impact factor: 16.240

9.  Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe.

Authors:  Marlieke E A de Kraker; Peter G Davey; Hajo Grundmann
Journal:  PLoS Med       Date:  2011-10-11       Impact factor: 11.069

Review 10.  Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field.

Authors:  Jan T Poolman; Michael Wacker
Journal:  J Infect Dis       Date:  2015-09-02       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.